Opportunities for Complement Therapy in China

Time: 3:30 pm
day: Day Two


  • Reflecting on the significant opportunities available for complement therapies in China
  • Examining how the considerations for development in China differ from US/EU
  • Outlining unique strategies that can be employed for approval of complement inhibitors in rare disease indications